As SCF/c-kit signaling is considered to be one of the most potent chemoattractants and activators of MCs, SCF-positive neoplastic cells contributed, in turn, to subsequent infiltration, differentiation, and survival of MCs, which would eventually enhance metastatic potential of breast cancer [33]. Here, KITLG is linked to breast carcinoma.